HLA-A*31:01

Overview
Prescribing Info
Drug Label Annotations
Clinical Annotations
Variant Annotations
Literature
Related To
Links
Navigate to...
Show section selector dropdown

Literature

The publications shown below are associated with this haplotype in PharmGKB based on (1) literature annotations, (2) variant annotations, (3) VIP summaries, or (4) pathways.

    41 items
    Literature
    The association between the number of HLA risk alleles and drug allergy and its implications for HLA screening - a case-control study.
    The pharmacogenomics journal. 2025. Manson Lisanne E N, Anholts Jacqueline D H, Drabbels Jos J M, Swen Jesse J, Roelen Dave L and Guchelaar Henk-Jan.
    PGx Paper Type: Implementation, Population Frequency
    Literature
    An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health System.
    International journal of molecular sciences. 2024. Taladriz-Sender Irene, Hernández-Osio Gina, Zapata-Cobo Paula, Salvador-Martín Sara, García-González Xandra, Balas Antonio, Sanjurjo-Sáez María and López-Fernández Luis A.
    PGx Paper Type: Methods
    Literature
    Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma.
    Anticancer research. 2024. Ollikainen Riina K, Sippola Antti, Turpeenniemi-Hujanen Taina, Kuitunen Hanne, Porvari Katja, Haapasaari Kirsi-Maria, Kuusisto Milla E L, Klaavuniemi Tuula and Kuittinen Outi.
    Literature
    Characterization of three novel HLA class I alleles, HLA-A*31:01:02:56, HLA-B*35:588 and HLA-B*57:153.
    HLA. 2024. Ulrich Silvia, Meitz Sandra, Posch Ursula and Schlenke Peter.
    Literature
    Discovery of the novel HLA-A*33:256 allele, a variant of HLA-A*33:03:01:01, by next-generation sequencing.
    HLA. 2024. Andryushkina Anna V, Ananeva Anastasiia, Gusev Oleg and Shagimardanova Elena I.
    Literature
    Identification of the novel HLA-A*03:01:123 allele in a Russian individual.
    HLA. 2024. Ananeva Anastasiia, Sergeeva Iuliia, Andryushkina Anna V and Shagimardanova Elena I.
    Literature
    Pharmacogenetic testing for prevention of severe cutaneous adverse drug reactions.
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 2024. Mushiroda Taisei.
    Literature
    Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at-risk patients.
    The Medical journal of Australia. 2023. Stojanova Jana, Day Richard O and Suthers Graeme.
    PGx Paper Type: Implementation, Population Frequency, Commentary
    Literature
    Pharmacogenetic allele variant frequencies: An analysis of the VA's Million Veteran Program (MVP) as a representation of the diversity in US population.
    PloS one. 2023. Markianos Kyriacos, Dong Frederic, Gorman Bryan, Shi Yunling, Dochtermann Daniel, Saxena Uma, Devineni Poornima, Moser Jennifer, Muralidhar Sumitra, Ramoni Rachel, Tsao Philip, Pyarajan Saiju, Przygodzki Ronald and Million Veteran Program.
    PGx Paper Type: Population Frequency, Methods
    Literature
    Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions.
    Frontiers in genetics. 2023. Manson Lisanne E N, Delwig Sander J, Drabbels Jos J M, Touw Daan J, De Vries Aiko P J, Roelen Dave L and Guchelaar Henk-Jan.
    PGx Paper Type: Implementation
    Literature
    An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice.
    Frontiers in pharmacology. 2022. Wang Chuang-Wei, Preclaro Ivan Arni C, Lin Wei-Hsiang and Chung Wen-Hung.
    PGx Paper Type: Implementation, Review
    Literature
    Genetic susceptibilities and prediction modeling of carbamazepine and allopurinol-induced severe cutaneous adverse reactions in Vietnamese.
    Pharmacogenomics. 2021. van Nguyen Dinh, Chu Hieu Chi, Vidal Christopher, Fulton Richard B, Nguyen Nguyet Nhu, Quynh Do Nga Thi, Tran Tu Linh, Nguyen Thuy Ninh, Thu Nguyen Ha Thi, Chu Hanh Hong, Thanh Thuc Huyen Thi, Minh Le Huong Thi, van Nunen Sheryl, Anderson Janet and Fernando Suran L.
    Pediatric
    Literature
    Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.
    Clinical pharmacology and therapeutics. 2019. Nicoletti Paola, Barrett Sarah, McEvoy Laurence, Daly Ann K, Aithal Guruprasad, Lucena M Isabel, Andrade Raul J, Wadelius Mia, Hallberg Pär, Stephens Camilla, Bjornsson Einar S, Friedmann Peter, Kainu Kati, Laitinen Tarja, Marson Anthony, Molokhia Mariam, Phillips Elizabeth, Pichler Werner, Romano Antonino, Shear Neil, Sills Graeme, Tanno Luciana K, Swale Ashley, Floratos Aris, Shen Yufeng, Nelson Matthew R, Watkins Paul B, Daly Mark J, Morris Andrew P, Alfirevic Ana and Pirmohamed Munir.
    Literature
    Antiepileptic drug-induced severe cutaneous adverse reactions and HLA alleles: A report of five cases with lymphocyte activation test.
    Translational and clinical pharmacology. 2019. Kim Eun-Young, Kim Mi-Yeong, Park Chan Sun, Choi Jae-Hyeog, Ghim Jong-Lyul, Kim Ho-Sook and Shin Jae-Gook.
    Literature
    Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
    JAMA neurology. 2018. Mushiroda Taisei, Takahashi Yukitoshi, Onuma Teiichi, Yamamoto Yoshiaki, Kamei Tetsumasa, Hoshida Tohru, Takeuchi Katsuya, Otsuka Kotaro, Okazaki Mitsutoshi, Watanabe Masako, Kanemoto Kosuke, Oshima Tomohiro, Watanabe Atsushi, Minami Shiro, Saito Kayoko, Tanii Hisashi, Shimo Yasushi, Hara Minoru, Saitoh Shinji, Kinoshita Toshihiko, Kato Masaki, Yamada Naoto, Akamatsu Naoki, Fukuchi Toshihiko, Ishida Shigenobu, Yasumoto Shingo, Takahashi Atsushi, Ozeki Takeshi, Furuta Takahisa, Saito Yoshiro, Izumida Nobuyuki, Kano Yoko, Shiohara Tetsuo, Kubo Michiaki and GENCAT Study Group.
    PGx Paper Type: Implementation
    Pediatric
    Literature
    Single-tube multiplex real-time PCR assay for rapid and reliable detection of HLA-A*31:01 allele.
    Pharmacogenomics. 2018. Zhang Tingting, Xiao Ying, Wang Yanxia, Li Yanwei, Zhang Lirong, Chen Chao and Wang Huijuan.
    Literature
    HLA-A*31:01 and Oxcarbazepine-Induced DRESS in a Patient With Seizures and Complete DCX Deletion.
    Pediatrics. 2018. Kim Hyun, Chadwick Laura, Alzaidi Yasir, Picker Jonathan, Poduri Annapurna and Manzi Shannon.
    Pediatric
    Literature
    Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.
    Neurology. 2018. McCormack Mark, Gui Hongsheng, Ingason Andrés, Speed Doug, Wright Galen E B, Zhang Eunice J, Secolin Rodrigo, Yasuda Clarissa, Kwok Maxwell, Wolking Stefan, Becker Felicitas, Rau Sarah, Avbersek Andreja, Heggeli Kristin, Leu Costin, Depondt Chantal, Sills Graeme J, Marson Anthony G, Auce Pauls, Brodie Martin J, Francis Ben, Johnson Michael R, Koeleman Bobby P C, Striano Pasquale, Coppola Antonietta, Zara Federico, Kunz Wolfram S, Sander Josemir W, Lerche Holger, Klein Karl Martin, Weckhuysen Sarah, Krenn Martin, Gudmundsson Lárus J, Stefánsson Kári, Krause Roland, Shear Neil, Ross Colin J D, Delanty Norman, EPIGEN Consortium;, Pirmohamed Munir, Carleton Bruce C, Canadian Pharmacogenomics Network for Drug Safety;, Cendes Fernando, Lopes-Cendes Iscia, Liao Wei-Ping, O'Brien Terence J, Sisodiya Sanjay M, EpiPGX Consortium;, Cherny Stacey, Kwan Patrick, Baum Larry, International League Against Epilepsy Consortium on Complex Epilepsies; and Cavalleri Gianpiero L.
    Literature
    HLA-A*31: 01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population.
    Pharmacogenetics and genomics. 2017. Khor Amy Hui-Ping, Lim Kheng-Seang, Tan Chong-Tin, Kwan Zhenli, Tan Wooi-Chiang, Wu David Bin-Chia and Ng Ching-Ching.
    Pediatric
    Literature
    Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.
    Seizure. 2017. Kay Lara, Willems Laurent M, Zöllner Johann Philipp, Reif Philipp S, Klein Karl Martin, Rosenow Felix and Strzelczyk Adam.
    Literature
    Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population.
    Pharmacological research. 2017. Ramírez Elena, Bellón Teresa, Tong Hoi Y, Borobia Alberto M, de Abajo Francisco J, Lerma Victoria, Moreno Hidalgo Miguel A, Castañer José L, Cabañas Rosario, Fiandor Ana, González-Ramos Jessica, Herranz Pedro, Cachafeiro Lucía, González-Herrada Carlos, González Olga, Aramburu José A, Laosa Olga, Hernández Rafael, Carcas Antonio J and Frías Jesús.
    Pediatric
    Literature
    HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
    Epilepsia. 2016. Moon Jangsup, Kim Tae-Joon, Lim Jung-Ah, Sunwoo Jun-Sang, Byun Jung-Ick, Lee Soon-Tae, Jung Keun-Hwa, Park Kyung-Il, Jung Ki-Young, Jeon Daejong, Yu Kyung-Sang, Jang In-Jin, Chu Kon and Lee Sang Kun.
    Pediatric
    Literature
    HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.
    The pharmacogenomics journal. 2014. Genin E, Chen D-P, Hung S-I, Sekula P, Schumacher M, Chang P-Y, Tsai S-H, Wu T-L, Bellón T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung W-H, Mockenhaupt M and Roujeau J-C.
    Literature
    Pharmacogenetics of antiepileptic drug-induced hypersensitivity.
    Pharmacogenomics. 2014. Bloch Katarzyna M, Sills Graeme J, Pirmohamed Munir and Alfirevic Ana.
    Literature
    Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Journal of dermatological science. 2014. Hsiao Yi-Hsin, Hui Rosaline Chung-Yee, Wu Tony, Chang Wan-Chun, Hsih Mo-Song, Yang Chih-Hsun, Ho Hsin-Chun, Chang Ya-Ging, Chen Ming-Jing, Lin Jing-Yi, Chen Ding-Ping, Chang Pi-Yueh, Wu Tsu-Lan, Hung Shuen-Iu and Chung Wen-Hung.
    Pediatric
    Literature
    HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis.
    Pharmacogenetics and genomics. 2014. Grover Sandeep and Kukreti Ritushree.
    Literature
    HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
    Pharmacogenomics. 2014. Fricke-Galindo Ingrid, Martínez-Juárez Iris E, Monroy-Jaramillo Nancy, Jung-Cook Helgi, Falfán-Valencia Ramcés, Ortega-Vázquez Alberto, Alonso-Vilatela María Elisa and López-López Marisol.
    Pediatric
    Literature
    Integrating pharmacogenetic information and clinical decision support into the electronic health record.
    Journal of the American Medical Informatics Association : JAMIA. 2014. Goldspiel Barry R, Flegel Willy A, DiPatrizio Gary, Sissung Tristan, Adams Sharon D, Penzak Scott R, Biesecker Leslie G, Fleisher Thomas A, Patel Jharana J, Herion David, Figg William D, Lertora Juan J L and McKeeby Jon W.
    Literature
    HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population.
    Journal of dermatological science. 2013. Niihara Hiroyuki, Kaneko Sakae, Ito Takahumi, Sugamori Takashi, Takahashi Nobuyuki, Kohno Kunie and Morita Eishin.
    Literature
    HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.
    Clinical pharmacology and therapeutics. 2013. Amstutz U, Ross C J D, Castro-Pastrana L I, Rieder M J, Shear N H, Hayden M R, Carleton B C and CPNDS Consortium.
    Pediatric
    Literature
    A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
    The pharmacogenomics journal. 2013. Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z and Japan Pharmacogenomics Data Science Consortium.
    Literature
    HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.
    Clinical pharmacology and therapeutics. 2012. Yip V L, Marson A G, Jorgensen A L, Pirmohamed M and Alfirevic A.
    Literature
    Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?
    Basic & clinical pharmacology & toxicology. 2012. Shi Yi-Wu, Min Fu-Li, Qin Bin, Zou Xin, Liu Xiao-Rong, Gao Mei-Mei, Wang Qian, Zhou Jue-Qian and Liao Wei-Ping.
    Pediatric
    Literature
    HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population.
    The Journal of dermatology. 2012. Niihara Hiroyuki, Kakamu Takeyasu, Fujita Yasuyuki, Kaneko Sakae and Morita Eishin.
    Literature
    Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.
    Epilepsy research. 2011. Kim Sae-Hoon, Lee Kyung Wha, Song Woo-Jung, Kim Sang-Heon, Jee Young-Koo, Lee Sang-Min, Kang Hye-Ryun, Park Heung-Woo, Cho Sang-Heon, Park Seong-Ho, Min Kyung-Up, Chang Yoon-Seok and Adverse Drug Reaction Research Group in Korea.
    Literature
    Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
    Human molecular genetics. 2011. Ozeki Takeshi, Mushiroda Taisei, Yowang Amara, Takahashi Atsushi, Kubo Michiaki, Shirakata Yuji, Ikezawa Zenro, Iijima Masafumi, Shiohara Tetsuo, Hashimoto Koji, Kamatani Naoyuki and Nakamura Yusuke.
    Pediatric
    Literature
    HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
    The New England journal of medicine. 2011. McCormack Mark, Alfirevic Ana, Bourgeois Stephane, Farrell John J, Kasperavičiūtė Dalia, Carrington Mary, Sills Graeme J, Marson Tony, Jia Xiaoming, de Bakker Paul I W, Chinthapalli Krishna, Molokhia Mariam, Johnson Michael R, O'Connor Gerard D, Chaila Elijah, Alhusaini Saud, Shianna Kevin V, Radtke Rodney A, Heinzen Erin L, Walley Nicole, Pandolfo Massimo, Pichler Werner, Park B Kevin, Depondt Chantal, Sisodiya Sanjay M, Goldstein David B, Deloukas Panos, Delanty Norman, Cavalleri Gianpiero L and Pirmohamed Munir.
    Literature
    Drugs@FDA: Drug Product Tegretol (carbamazepine), NDA016608, REMEDYREPACK INC.
    Literature
    Drugs@HCSC: Drug Product APO-OXCARBAZEPINE (oxcarbazepine), APOTEX INC
    Literature
    Drugs@HCSC: Drug Product TEGRETOL (carbamazepine), Novartis Pharmaceuticals Canada Inc.
    Literature
    Swissmedic label for carbamazepine